Search

Your search keyword '"Duvoux, Christophe"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Duvoux, Christophe" Remove constraint Author: "Duvoux, Christophe" Database Academic Search Index Remove constraint Database: Academic Search Index
61 results on '"Duvoux, Christophe"'

Search Results

1. Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.

2. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation.

Catalog

Books, media, physical & digital resources

3. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS).

4. Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.

5. ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.

6. Anonymous living donation in liver transplantation: Squaring the circle or condemned to vanish?

7. Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.

8. Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin

9. LBP06 - Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study.

10. Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosis

11. PS-211-Liver transplantation for HCC: Applicability and performance of the AFP score in real life. The French organization for organ sharing (ABM) experience.

12. Cutaneous Phaeohyphomycosis Caused by Veronaea bothryosa in a Liver Transplant Recipient Successfully Treated with Itraconazole.

13. Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study.

14. Long‐term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 years.

15. Liver transplantation for autoimmune hepatitis: Pre‐transplant does not predict the early post‐transplant outcome.

16. Diagnosis and management of hepatic encephalopathy: The French recommendations.

17. Long-Term Results of Endoscopic Metal Stenting for Biliary Anastomotic Stricture after Liver Transplantation.

18. Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

19. Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.

21. Determination of serine/threonine protein phosphatase type 2B (PP2B) in lymphocytes by HPLC

22. Microsporidiosis after liver transplantation: A French nationwide retrospective study.

23. THU-494 Selective internal radiation therapy for unresectable hepatocellular carcinoma in a tertiary center in France, update and final analysis.

24. SAT-048 Long-term mortality and risk factors associated with mortality after liver transplantation in the modern era.

25. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation.

26. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score.

27. Impact of COVID‐19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry.

28. Liver transplantation in patients with sickle cell disease: possible but challenging—a cohort study.

29. HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis.

30. Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.

31. Impact of the new MELD‐based allocation system on waiting list and post‐transplant survival—a cohort analysis using the French national CRISTAL database.

32. Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.

33. Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades.

34. Delisting HCV‐infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting.

35. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.

36. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.

37. Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry.

38. Locoregional treatments before liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry.

39. Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.

40. External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry.

41. Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.

42. More on Bevacizumab in Hereditary Hemorrhagic Telangiectasia.

43. Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.

44. Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study.

45. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study.

46. A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases.

47. Liver resection for hepatocellular carcinoma in 313 Western patients: Tumor biology and underlying liver rather than tumor size drive prognosis.

48. Long term results of liver transplantation for Wilson’s disease: Experience in France.

49. Evaluation of the Architect® tacrolimus assay in kidney, liver, and heart transplant recipients

50. Outcomes in adult recipients of right-sided liver grafts in split-liver procedures.